Stock SENS SENSEONICS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Senseonics Holdings, Inc.

Equities

SENS

US81727U1051

Market Closed - Nyse
Other stock markets
 04:00:00 2024-06-14 pm EDT 		5-day change 1st Jan Change
0.3914 USD +1.66% Intraday chart for Senseonics Holdings, Inc. -4.54% -31.35%
May. 13 Transcript : Senseonics Holdings, Inc., Q1 2024 Earnings Call, May 13, 2024
May. 13 Senseonics Holdings, Inc. Provides Earnings Guidance for the First Half 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association’s 84th Scientific Sessions
BU
Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference
BU
Senseonics: Q1 Earnings Snapshot
AQ
Transcript : Senseonics Holdings, Inc., Q1 2024 Earnings Call, May 13, 2024
Senseonics Holdings, Inc. Provides Earnings Guidance for the First Half 2024
CI
Earnings Flash (SENS) SENSEONICS HOLDINGS Posts Q1 Revenue $5.1M, vs. Street Est of $4.6M
MT
Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results
BU
Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management
BU
Senseonics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Senseonics Holdings, Inc. and Mercy Collaborate to Improve Diabetes Population Health Management
CI
Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution
BU
Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution
CI
Senseonics Holdings, Inc. to Participate in Upcoming Conferences
BU
Senseonics Holdings, Inc. - Eversense CGM System Receives iCGM Designation by the US FDA
AQ
Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time
BU
Eversense® CGM System Receives iCGM Designation by the US FDA
BU
Senseonics Holdings, Inc. Announces Eversense CGM System Receives iCGM Designation by the U.S. Food and Drug Administration
CI
Senseonics Holdings, Inc. Announces Board Changes
CI
Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
BU
Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SENS Stock
  4. News Senseonics Holdings, Inc.